Share this article
Share this article
SHANGHAI and HONG KONG, March 14, 2021 /PRNewswire/ Antengene Corporation Limited ( Antengene , SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced that the company has been selected as an eligible stock in the Shenzhen-Hong Kong Stock Connect, effective from March 15, 2021.
Shenzhen-Hong Kong Stock Connect is a mutual stock market access mechanism between the Mainland and Hong Kong under which Shenzhen Stock Exchange and The Stock Exchange of Hong Kong Limited have established technical connectivity to enable investors in the Mainland and Hong Kong to trade eligible shares listed on the other s market through their local securities companies or brokers.
Scholar Education : VOLUNTARY ANNOUNCEMENT - INCLUSION IN THE HONG KONG STOCK CONNECT LIST UNDER THE SHENZHEN-HONG KONG STOCK CONNECT
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Antengene Included in the Shenzhen-Hong Kong Stock Connect
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.